Beese Fulmer Investment Management, Inc. Gilead Sciences, Inc. Transaction History

Beese Fulmer Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	SELL	$77.31 - $88.08 $1,391 - $1,585	-18 Reduced 0.69%	2,590 $214,000
Q4 2022 Jan 17, 2023	BUY	$62.32 - $89.47 $162,530 - $233,337	2,608 New	2,608 $0
Q3 2020 Oct 08, 2020	SELL	$62.1 - $78.08 $135,378 - $170,214	-2,180 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$72.34 - $84.0 $157,701 - $183,120	2,180 New	2,180 $168,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.